Subscribe To
As demand for covid vaccines falls, astrazeneca lines up 'blockbuster' products for 2023
Demand for Covid-19 vaccines has dropped, but AstraZeneca has "blockbuster" projects in development tha...
February 9, 2023, 7:55 am
Pandemic profits in healthcare
Pfizer and Moderna profited by developing vaccines at a breakneck pace, but should investors add them t...
February 9, 2023, 4:26 am
Astrazeneca plc modestly undershoots consensus in the fourth quarter; targeting low double digit sales growth this year
Drug maker AstraZeneca PLC (LSE:AZN)'s fourth quarter numbers marginally undershot consensus as it felt the impact of declining sales of its Covid v...
February 9, 2023, 3:10 am
Big pharma's big gains
Given enough time, stock in pharmaceutical giants has yielded life-altering gains. Because of its popular and widely distributed COVID-19 v...
February 9, 2023, 2:14 am
Vaxcyte to present at the svb securities global biopharma conference
SAN CARLOS, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccin...
February 7, 2023, 9:05 pm
Should investors buy or sell the vaccinex patent news?
Shares of Vaccinex, Inc. (NASDAQ: VCNX) are charging higher on February 7 on news that the clinical-sta...
February 7, 2023, 11:10 am
Why is vaccinex (vcnx) stock up 67% today?
Vaccinex (NASDAQ: VCNX ) stock is rocketing higher on Tuesday despite a lack of news from the clinical-...
February 7, 2023, 7:41 am
Key words: bill gates to elon musk: ‘don’t go to mars’
The Microsoft co-founder calls for spending money on measles vaccines vs. space travel—but he thinks ...
February 5, 2023, 5:57 pm
Sanofi sa (sny) q4 2022 earnings call transcript
Sanofi SA (NASDAQ:SNY ) Q4 2022 Results Conference Call February 3, 2023 8:00 AM ET Company Participants Eva Schaefer-Jansen - Head, IR Paul Hudson - ...
February 3, 2023, 3:08 pm
Novavax shares jumped in january while others slipped
At the start of 2023, vaccine developer Novavax, Inc. (NASDAQ: NVAX) saw a much-needed jump from near-h...
February 2, 2023, 12:06 pm
Gsk's beats on q4 earnings & sales, issues upbeat 2023 outlook
GSK's (GSK) revenues benefit from strong growth in sales across all segments, especially Shingrix vaccin...
February 1, 2023, 12:02 pm
Gsk ceo emma walmsley on beating q4 earnings
GlaxoSmithKline CEO Emma Walmsley joins 'Squawk Box' to discuss company's growth drivers this quarter, the company's Shingles v...
February 1, 2023, 9:29 am
Gsk bidding to be first with an rsv vaccine. here's our 2-minute guide
We heard earlier on Wednesday that GSK PLC (LSE:GSK, NYSE:GSK) could be the first to the market with a drug for RSV, a cold-like condition that can be...
February 1, 2023, 9:16 am
Arcturus' mrna platform: the future of quick and efficient vaccine delivery
Arcturus is revolutionizing biotechnology with its cutting-edge mRNA vaccines and delivery systems. The...
February 1, 2023, 4:01 am
Gsk 'beats the street'; enters '23 with strong momentum
GSK PLC (LSE:GSK, NYSE:GSK) has reported better-than-expected fourth-quarter results, largely due to strong sales of its popular shingles v...
February 1, 2023, 2:44 am
Gsk posts higher sales and profit of $1.85 billion, lifted by specialty medicines and vaccines businesses
GSK PLC on Wednesday posted rising earnings and sales for the fourth quarter, which the company said were boosted by its specialty medicines and v
February 1, 2023, 2:43 am
Gsk q4 results beat expectations, helped by shingrix
GSK on Wednesday beat fourth-quarter profit and sales forecasts helped by sales of its blockbuster shingles va...
February 1, 2023, 2:20 am
: pfizer’s covid revenues have dropped off along with attention to the pandemic
Wall Street urged Pfizer to lower its COVID revenue estimates. The company did — but it’s still betting on higher demand for its v...
January 31, 2023, 6:16 pm
Pfizer can't catch a break, but investors can
Shares of Pfizer Inc. ( PFE , Financial) fell 15% in the month of January, ending the month on a low note with an earnings report that included a lack...
January 31, 2023, 6:10 pm
Moderna's stock is down as pfizer lowers revenue estimates for its covid vaccine for 2023
Moderna Inc.'s MRNA shares were down 2.8% in trading on Tuesday. Pfizer Inc. PFE, which makes a competing COVID-19 v...
January 31, 2023, 1:52 pm